Get to know our team – Chief Financial Officer Matthew Gepp

We are pleased to welcome Matthew Gepp to our senior management team as Chief Financial Officer (CFO) from 7 June 2021. Matthew will be based in the Sydney office.

Matthew joins Alcidion with 17 years’ experience holding senior finance and leadership positions, including the CFO of ASX listed technology and software companies, MNF Group Limited and Engin Limited.  He also has 10 years of international experience in financial and operational roles in London and Europe.  He has a proven track record of delivering upon financial objectives and in his most recent position as CFO of MNF Group, oversaw the successful acquisition and integration of several businesses as part of their growth strategy.  Matthew is a member of the Chartered Accountants Australia & New Zealand and holds a Bachelor of Economics (Accounting) from Macquarie University.

On his joining Alcidion, Matthew said “I am delighted to be joining Alcidion at what is clearly an exciting time for the company and the digital health sector as a whole. I look forward to working closely with the Board and the Senior Leadership Team and to play a critical role supporting the ongoing growth trajectory of the business.”

Colin MacKinnon, who currently holds the dual role of Chief Operating Officer (COO) and CFO, will continue as COO overseeing the group’s operations.  This appointment supports Alcidion’s planned growth objectives, allowing Colin to focus full time on his role as COO.

Alcidion Managing Director Kate Quirke said, “I am very pleased to welcome Matthew to Alcidion as Chief Financial Officer. After a considered recruitment process, Matthew was identified as an excellent candidate due to his extensive experience with ASX listed companies in the technology and software sectors, helping them to scale organically and through acquisition and operate across international markets.”

“I look forward to working with Matthew, both as a member of our Senior Leadership Team and as advisor to the Board, as we continue to transform the delivery of healthcare and execute upon our objectives of becoming a leading global healthcare organisation.”